Established and emerging use of sodium-glucose cotransporter-2 inhibitors in pediatric population with type 2 diabetes: a case report and literature review

The incidence and prevalence of type 2 diabetes (T2D) are increasing worldwide, affecting both adults and a growing number of children and adolescents. Notably, youth-onset T2D differs in its pathogenesis from later-onset T2D and progresses more rapidly. It is associated with a higher incidence of c...

Descripció completa

Dades bibliogràfiques

Autors principals:	Valeria Castorani, Eleonora Chiarle, Silvia Savastio, Erica Pozzi, Cristina Partenope, Ciro Pignatiello, Sotirios Dimarakis, Monica Demichelis, Federico Medina, Ivana Rabbone
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-09-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	type 2 diabetes children SGLT2 inhibitors empagliflozin hyperglycemia
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1629488/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!